Daniel Joseph Apel, CFO: Arrowhead Pharmaceuticals ARWR Planned sale · Filed 04/22

Trade details

Type: Planned sale notice
Stock: Arrowhead Pharmaceuticals ARWR
Person: Daniel Joseph ApelCFO
Planned sale date: 26/04/22
Filed: 26/04/22

$934.2K to be sold

Arrowhead Pharmaceuticals trades, last 26 weeks

What else happened in Arrowhead Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 03/23~05/22

Daniel Joseph Apel's recent trades

Daniel Joseph ApelCFO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$627.9K
8,730 sh
$627.9K
Filed 04/24
Traded 04/22
Daniel Joseph ApelCFO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$224.9K
3,208 sh
$224.9K
Filed 04/24
Traded 04/22
Daniel Joseph ApelCFO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$81.5K
1,157 sh
$81.5K
Filed 04/24
Traded 04/22

Daniel Joseph Apel, CFO — plans to sell 13,095 sh of Arrowhead Pharmaceuticals ARWR · $934.2K · around 04/22 | Whalegun